Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Michael Gough

Showing results (21-30 of 40) with videos related to

Pageof 4
Sort By:
Molecular Therapy. Methods & Clinical Development|April 13, 2016
Preclinical safety, pharmacokinetics, pharmacodynamics, and biodistribution studies with Ad35K++ protein: a novel rituximab cotherapeuticMaximilian Richter, Roma Yumul, Kamola Saydaminova, et al.
Molecular Therapy. Methods & Clinical Development|June 2, 2015
Preclinical safety and efficacy studies with an affinity-enhanced epithelial junction opener and PEGylated liposomal doxorubicinMaximilian Richter, Roma Yumul, Hongjie Wang, et al.
Nature Biotechnology|August 10, 2004
A simple method to cure established tumors by inflammatory killing of normal cellsGregory A Daniels, Luis Sanchez-Perez, Rosa Maria Diaz, et al.
Molecular Therapy : the Journal of the American Society of Gene Therapy|October 24, 2012
Transient removal of CD46 is safe and increases B-cell depletion by rituximab in CD46 transgenic mice and macaquesInes Beyer, Hua Cao, Jonas Persson, et al.
Blood|January 25, 2003
Interleukin-7 improves CD4 T-cell reconstitution after autologous CD34 cell transplantation in monkeysJan Storek, Thurman Gillespy, Hailing Lu, et al.
Plos One|January 5, 2012
Choriodecidual group B streptococcal inoculation induces fetal lung injury without intra-amniotic infection and preterm labor in Macaca nemestrinaKristina M Adams Waldorf, Michael G Gravett, Ryan M McAdams, et al.
Frontiers in Immunology|August 1, 2020
Characterization of a Novel Compound That Stimulates STING-Mediated Innate Immune Activity in an Allele-Specific MannerJinu Abraham, Sara Botto, Nobuyo Mizuno, et al.
NPJ Precision Oncology|July 2, 2025
A novel structural modeling magnitude and orientation radiomic descriptor for evaluating response to neoadjuvant therapy in rectal cancers via MRICharlems Alvarez-Jimenez, Jacob T Antunes, Thomas DeSilvio, et al.
Journal for Immunotherapy of Cancer|May 8, 2021
Neoadjuvant immunoradiotherapy results in high rate of complete pathological response and clinical to pathological downstaging in locally advanced head and neck squamous cell carcinomaRom Leidner, Marka Crittenden, Kristina Young, et al.
Mbio|May 4, 2017
A Novel Agonist of the TRIF Pathway Induces a Cellular State Refractory to Replication of Zika, Chikungunya, and Dengue VirusesKara M Pryke, Jinu Abraham, Tina M Sali, et al.
Pageof 4

Showing results (21-30 of 40) with videos related to

Sort By:
Pageof 4
Molecular Therapy. Methods & Clinical Development|April 13, 2016
Preclinical safety, pharmacokinetics, pharmacodynamics, and biodistribution studies with Ad35K++ protein: a novel rituximab cotherapeuticMaximilian Richter, Roma Yumul, Kamola Saydaminova, et al.
Molecular Therapy. Methods & Clinical Development|June 2, 2015
Preclinical safety and efficacy studies with an affinity-enhanced epithelial junction opener and PEGylated liposomal doxorubicinMaximilian Richter, Roma Yumul, Hongjie Wang, et al.
Nature Biotechnology|August 10, 2004
A simple method to cure established tumors by inflammatory killing of normal cellsGregory A Daniels, Luis Sanchez-Perez, Rosa Maria Diaz, et al.
Molecular Therapy : the Journal of the American Society of Gene Therapy|October 24, 2012
Transient removal of CD46 is safe and increases B-cell depletion by rituximab in CD46 transgenic mice and macaquesInes Beyer, Hua Cao, Jonas Persson, et al.
Blood|January 25, 2003
Interleukin-7 improves CD4 T-cell reconstitution after autologous CD34 cell transplantation in monkeysJan Storek, Thurman Gillespy, Hailing Lu, et al.
Plos One|January 5, 2012
Choriodecidual group B streptococcal inoculation induces fetal lung injury without intra-amniotic infection and preterm labor in Macaca nemestrinaKristina M Adams Waldorf, Michael G Gravett, Ryan M McAdams, et al.
Frontiers in Immunology|August 1, 2020
Characterization of a Novel Compound That Stimulates STING-Mediated Innate Immune Activity in an Allele-Specific MannerJinu Abraham, Sara Botto, Nobuyo Mizuno, et al.
NPJ Precision Oncology|July 2, 2025
A novel structural modeling magnitude and orientation radiomic descriptor for evaluating response to neoadjuvant therapy in rectal cancers via MRICharlems Alvarez-Jimenez, Jacob T Antunes, Thomas DeSilvio, et al.
Journal for Immunotherapy of Cancer|May 8, 2021
Neoadjuvant immunoradiotherapy results in high rate of complete pathological response and clinical to pathological downstaging in locally advanced head and neck squamous cell carcinomaRom Leidner, Marka Crittenden, Kristina Young, et al.
Mbio|May 4, 2017
A Novel Agonist of the TRIF Pathway Induces a Cellular State Refractory to Replication of Zika, Chikungunya, and Dengue VirusesKara M Pryke, Jinu Abraham, Tina M Sali, et al.
Pageof 4